Aurobindo Pharma Ltd. (AUROPHARMA): Aurobindo Pharma Share Price hits fresh 52-week high at Rs 1,686.50
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Aurobindo Pharma Share Price moved to Rs 1,686.50, up 2.21% from Rs 1,650, after touching a fresh 52-week high of Rs 1,694.55. The company’s market capitalisation stands at Rs 94,937.35 crore. The price event is clear in the supplied market data, while the data itself does not establish a company-specific catalyst. For readers tracking Aurobindo Pharma Share Price Today, the move places AUROPHARMA in focus in the Indian stock market and in Stocks in News discussions on Univest.
The session opened at Rs 1,632.35 and also marked the day’s low, before the stock matched its yearly high at Rs 1,694.55. Turnover stood at Rs 5.9 crore. Univest notes that the event confirms a fresh 52-week high, so the main question for Aurobindo Pharma Share News is how the price action compares with its recent benchmarks and what the financial backdrop adds to the stock analysis.
Aurobindo Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,686.5 |
| Previous Close | Rs 1,650 |
| Today's Move | +Rs 36.5 (+2.21%) |
| Open | Rs 1,632.35 |
| High | Rs 1,694.55 |
| Low | Rs 1,632.35 |
| Turnover | Rs 5.9 crore |
| Market Capitalisation | Rs 94,937.35 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,686.5 versus the previous close of Rs 1,650, a rise of 2.21%. The stock opened at Rs 1,632.35, reached a high of Rs 1,694.55 and touched a low of Rs 1,632.35.
Aurobindo Pharma Share Price Today showed a firm session by closing at Rs 1,686.50 against the previous close of Rs 1,650, a gain of Rs 36.50 or 2.21%. The stock opened at Rs 1,632.35, which was also the day’s low, and climbed to Rs 1,694.55, its fresh 52-week high and day high. Turnover of Rs 5.9 crore provides the traded-value context for the move, while the price finish remained near the session peak.
Because the current price is above the previous 52-week high reference available in the data, the breakout percentage can be read directly from the move to the new yearly high. This keeps Aurobindo Pharma Share Price within the 52 Week High Stocks conversation without converting the event into anything beyond the supplied figures. In Univest’s coverage of Aurobindo Pharma Share Price News, the key fact is the new peak itself rather than any unsupported catalyst.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 94,937.35 crore |
| P/E Ratio | 25.57x |
| P/B Ratio | 2.44x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.24% |
Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 25.57x, P/B 2.44x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.
Aurobindo Pharma Ltd. has a market capitalisation of Rs 94937.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.57x, P/B at 2.44x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.31x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.57x |
| Benchmark Median P/E | 31.31x |
| Benchmark Average P/E | 48.24x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 2.44x |
| Benchmark Median P/B | 2.89x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 94,937.35 crore |
| Benchmark Median Market Cap | Rs 630.79 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.57x, which is below the benchmark median of 31.31x, a difference of -18.33%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.78%, a difference of -15.7%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.61%, a difference of -6.25%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 98,308.6 | 30.51 | 2.58 | 11.69 | 13.75 |
| Mankind Pharma Ltd. | MANKIND | 98,598.66 | 48.27 | 5.86 | 12.69 | 13.24 |
| Lupin Ltd. | LUPIN | 99,455.32 | 17.99 | 4.18 | 27.11 | 28.86 |
| Laurus Labs Ltd. | LAURUSLABS | 1,04,566.62 | 95.64 | 18.54 | 18.31 | 18.2 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.57x compared with the displayed peer median of 33.99x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 94,937.35 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price closed at Rs 1,686.50 after touching Rs 1,694.55, its fresh 52-week high.
- The day move was Rs 36.50, or 2.21%, versus the previous close of Rs 1,650.
- Market capitalisation is Rs 94,937.35 crore, and turnover was Rs 5.9 crore in the session.
- P/E stands at 25.57 and P/B at 2.44, both below the industry median in the supplied benchmark set.
- EPS is Rs 64.52, book value per share is Rs 676.49 and dividend yield is 0.24%.
About Aurobindo Pharma
Aurobindo Pharma Ltd. is listed on NSE and BSE and operates in Healthcare, within the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its market capitalisation, valuation ratios, earnings metrics and return measures. In Univest coverage, Aurobindo Pharma Share Price is discussed as a listed pharma stock with benchmarked financial and sector context.
The available company profile data supports a factual view of Aurobindo Pharma Stock News around its share price, market cap and financial ratios. Readers following Aurobindo Pharma Latest News can use Univest to track the share price, share price update, market cap, earnings and shareholding pattern in one place.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Aurobindo Pharma Share Price on Univest for live price updates, market capitalisation, 52-week levels, valuation ratios, earnings metrics, sector context and shareholding pattern. Univest also presents Aurobindo Pharma Share Price Today, Aurobindo Pharma Stock Analysis and Aurobindo Pharma Fundamental Analysis in a structured view for quick reading.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Aurobindo Pharma Share Price hit a fresh 52-week high?
Ans. The supplied market data confirms Aurobindo Pharma Share Price touched Rs 1,694.55, a fresh 52-week high. It does not establish a company-specific catalyst, so the event should be read as a verified price outcome.
What is Aurobindo Pharma Share Price Today?
Ans. Aurobindo Pharma Share Price Today is Rs 1,686.50, up Rs 36.50 or 2.21% from the previous close of Rs 1,650. The stock also touched Rs 1,694.55 during the session. The stock moved 2.21% during the session.
What is the market capitalisation of Aurobindo Pharma?
Ans. Aurobindo Pharma has a market capitalisation of Rs 94,937.35 crore. That places it well above the industry median in the supplied benchmark set and gives size context to Aurobindo Pharma Share Price.
How do Aurobindo Pharma’s valuation ratios compare with the sector?
Ans. Aurobindo Pharma trades at a P/E of 25.57 and a P/B of 2.44. Both sit below the supplied industry medians of 31.31 and 2.89, respectively, in the Pharmaceuticals & Drugs benchmark set.
What do EPS, book value and dividend yield show for Aurobindo Pharma Share Price?
Ans. EPS is Rs 64.52, book value per share is Rs 676.49, and dividend yield is 0.24%. These figures provide earnings, asset backing and payout context around Aurobindo Pharma Share Price.
How does Aurobindo Pharma compare with peers?
Ans. Aurobindo Pharma’s market cap of Rs 94,937.35 crore is near Dr. Reddy’s and Lupin in the supplied peer set. Its P/E is below several peers, while ROE and ROCE are below Lupin’s higher return ratios.
